BIOAF
Price:
$0.0002
Market Cap:
$397.07K
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). It has research collaborations with Aposense Limited ...[Read more]
Industry
Biotechnology
IPO Date
2010-12-31
Stock Exchange
OTC
Ticker
BIOAF
According to Bioasis Technologies Inc.’s latest financial reports and current stock price. The company's current ROE is 392.02%. This represents a change of 1.01% compared to the average of 35.27% of the last 4 quarters.
The mean historical ROE of Bioasis Technologies Inc. over the last ten years is -150.13%. The current 392.02% ROE has changed -361.12% with respect to the historical average. Over the past ten years (40 quarters), BIOAF's ROE was at its highest in in the May 2021 quarter at 1.06%. The ROE was at its lowest in in the August 2018 quarter at -1237.90%.
Average
-150.13%
Median
-139.74%
Minimum
-1222.62%
Maximum
635.39%
Discovering the peaks and valleys of Bioasis Technologies Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 449.92%
Maximum Annual ROE = 635.39%
Minimum Annual Increase = -151.97%
Minimum Annual ROE = -1222.62%
| Year | ROE | Change |
|---|---|---|
| 2022 | 154.38% | -9.99% |
| 2021 | 171.52% | 5.13% |
| 2020 | 163.15% | -74.32% |
| 2019 | 635.39% | -151.97% |
| 2018 | -1222.62% | 48.56% |
| 2017 | -822.99% | 449.92% |
| 2016 | -149.66% | 5.80% |
| 2015 | -141.45% | -6.32% |
| 2014 | -150.99% | 9.39% |
| 2013 | -138.03% | -6.65% |
The current ROE of Bioasis Technologies Inc. (BIOAF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
163.02%
5-year avg
-19.63%
10-year avg
-150.13%
Bioasis Technologies Inc.’s ROE is less than IR Biosciences Holdings Inc. (47.28%), less than Easy Technologies Inc. (219.87%), less than Todos Medical Ltd. (83.70%), greater than enVVeno Medical Corporation (-61.45%), less than Regnum Corp. (101.39%), less than GB Sciences, Inc. (10.02%), less than BioLife Sciences Inc. (367.14%), less than GlobeStar Therapeutics Corporation (148.30%), greater than Banyan Corp. (-1409.54%), less than Rimrock Gold Corp. (7.04%),
| Company | ROE | Market cap |
|---|---|---|
| 47.28% | $128.12K | |
| 219.87% | $142.22K | |
| 83.70% | $14.08K | |
| -61.45% | $7.74M | |
| 101.39% | $2.29K | |
| 10.02% | $162.83K | |
| 367.14% | $156.68K | |
| 148.30% | $124.11K | |
| -1409.54% | $286.04K | |
| 7.04% | $156.15K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioasis Technologies Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bioasis Technologies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bioasis Technologies Inc.'s ROE?
How is the ROE calculated for Bioasis Technologies Inc. (BIOAF)?
What is the highest ROE for Bioasis Technologies Inc. (BIOAF)?
What is the 3-year average ROE for Bioasis Technologies Inc. (BIOAF)?
What is the 5-year average ROE for Bioasis Technologies Inc. (BIOAF)?
How does the current ROE for Bioasis Technologies Inc. (BIOAF) compare to its historical average?